Skip to content

Clinical trials

Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 3 Status: Unknown status Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20072
20081
20091
20132
20181
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
St. Anna Kinderkrebsforschung2
Alliance for Clinical Trials in Oncology1
Assistance Publique - Hôpitaux de Paris1
Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.1
Clatterbridge Centre for Oncology1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Gilead Sciences1
Japan Adult Leukemia Study Group1
Jonsson Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma19
Lymphoma7
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Large-Cell, Immunoblastic7
Lymphoma, Non-Hodgkin7
Burkitt Lymphoma6
Leukemia, Lymphocytic, Chronic, B-Cell6
Leukemia, Myeloid, Acute6
Lymphoma, B-Cell, Marginal Zone6
Lymphoma, Follicular6

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.